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Abstract
Background: The aim of this study was to evaluate the antimicrobial and antioxidant activities of the methanol
extract, fractions and isolated compounds from Entada abyssinica stem bark, plant used traditionally against
gastrointestinal infections.
Methods: The methanol extract of E. abyssinica stem bark was pre-dissolved in a mixture of methanol and water,
and then partitioned between n-hexane, ethyl acetate and n-butanol. The ethyl acetate portion was fractionated by
column chromatography and the structures of isolated compounds elucidated by analysis of spectroscopic data
and comparison with literature data. Antimicrobial activity was assayed by broth microdilution techniques on
bacteria and yeasts. The antioxidant activity was determined by DPPH radical scavenging method.
Results: Four known compounds [(5S,6R,8aR)-5-(carboxymethyl)-3,4,4a,5,6,7,8,8a-octahydro-5,6,8a-
trimethylnaphthalenecarboxylic acid (1), methyl 3,4,5-trihydroxybenzoate (2), benzene-1,2,3-triol (3) and 2,3-
dihydroxypropyltriacontanoate (4)] were isolated. Compared to the methanol extract, fractionation increased the
antibacterial activities of the n-hexane and ethyl acetate fractions, while the antifungal activities increased in ethyl
acetate, n-butanol and aqueous residue fractions. The isolated compounds were generally more active on bacteria
(9.7 to 156.2 μg/ml) than yeasts (78.1 to 312.5 μg/ml). Apart from compound 1, the three others displayed DPPH
·
scavenging activity (RSa), with RSa50 values of 1.45 and 1.60 μg/ml.
Conclusion: The results obtained from this study support the ethnomedicinal use of E. abyssinica in the treatment
of gastrointestinal infections and the isolated compounds could be useful in the standardisation of antimicrobial
phytomedicine from this plant.
Background
Exploring the healing power of plants is an ancient con-
cept. For many centuries people have been trying to
alleviate and treat diseases with different plant extracts
and formulations [1]. The interest in plants with antimi-
crobial properties has been revived because of current
problems associated with the use of antibiotics [2].
Many microbial infections lead to the production of
highly reactive molecules from the metabolism of oxy-
gen that can cause extensive damage to cells and tissues
[3]. The fact that microorganisms nowadays tend to
develop resistance towards drugs, coupled to the unde-
sirable side effects of certain antibiotics offer consider-
able potentials for the development of new effective
antimicrobial and antioxidant agents; medicinal plants
are a prolific source.
Entada abyssinica (Mimosaceae) is an understorey
forest deciduous tree, 3-15 m high, with a flat spreading
crown. It is widespread in central and eastern tropical
Africa [4]. It has a grey stem bark, glabrous leaves and
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is locally used in the treatment of coughs, rheumatic
and abdominal pains, and diarrhoea while the root or
leaf decoction is used in the treatment of fever and to
prevent miscarriage [5]. The fresh roots are used against
gonorrhoea [6].
Some biological activities of Entada abyssinica have
been reported. The leaves are highly active against Sem-
liki forest virus [7]. Weak antibacterial activities of the
methanol extract of E. abyssinica stem bark has been
reported by Fabry et al. [8]. A number of biologically
active compounds have been isolated from E. abyssinica
including a diastereoisomer of the clerodane type diter-
pene, kolavenol [9], flavonoids and phytosterol glyco-
sides [10] and kolavic acid derivatives [11].
However, to the best of our knowledge, no informa-
tion on its free radical scavenging activities is available.
This study was therefore designed to evaluate the possi-
ble beneficial antimicrobial and antioxidant potencies of
the methanol extract, fractions and compounds from
this plant.
Methods
Plant material, extraction and phytochemical screening
The stem bark of E. abyssinica was collected in May 2007
in Menoua Division, West Cameroon. Botanical identifi-
cation was done at the Cameroon National Herbarium in
Yaounde by Mr Tadjouteu Fulbert, where a voucher spe-
cimen was kept under the reference number 44732/
HNC. The stem bark was cut into pieces, air-dried under
shade and ground into powder using an electric grinder.
A mass of 375 g of powder was exhaustively extracted
with 1 l of methanol. After filtration, the solvent was eva-
porated under reduced pressure in a rotary evaporator at
45°C to afford the methanol extract (47.50 g). An amount
of 32.50 g of this extract was pre-dissolved in 100 ml of a
mixture of methanol and water (1:9) and then 400 ml of
n-hexane was added and shaken vigorously. After about
30 min, the n-hexane phase was collected and the process
repeated thrice. Methanol was then evaporated from the
polar phase and the aqueous residue treated sequentially
with ethyl acetate and n-butanol. The n-hexane, ethyl
acetate and n-butanol were evaporated under reduced
pressure in rotary evaporator to afford 4.64, 15.78 and
2.63 g of fractions respectively. The aqueous residue
(9.44 g) was obtained after drying the residual portion in
the oven at 40°C for 48 h. The methanol extract and frac-
tions were subjected to phytochemical screening using
standard procedures [12].
Fractionation and isolation
A quantity of 10.5 g of the ethyl acetate fraction was
subjected to silica gel 60 (0.20-0.500 mm) flash chroma-
tography and eluted with mixtures of n-hexane (Hex)
and ethyl acetate (EtOAc) of increasing polarity
(0-100%) to yield a total of 9 fractions of 200 ml each.
These fractions were combined on the basis of TLC
profiles into four major fractions: F1 [4.77 g, Hex/
EtOAc (100:0), (80:20), (70:30)], F2 [2.48 g, Hex/EtOAc
(60:40), (50:50)], F3 [1.56 g, Hex/EtOAc (40:60)] and F4
[0.63 g, Hex/EtOAc (30:70), (20:80), (0:100)]. Fraction
F1 was further dissolved in a mixture of Hex and
EtOAc (60:40) and a whitish compound precipitated. It
was filtered and rinsed with EtOAc to afford compound
1 (100 mg). The filtrate (4.5 g) was subjected to further
silica gel column chromatography (0.063-0.200 mm) to
afford compound 2 (113 mg). Fraction F3 afforded com-
pound 3 (108 mg) as a yellowish powder from the mix-
ture Hex/EtOAc (60:40). Fraction F4 was further
subjected to column chromatography (0.063-0.200 mm)
purification using Hex and EtOAc (40:60) to afford
compound 4 (54 mg).
Chemical analysis
The n-hexane fraction was subjected to GC-MS using
an Agilent 6890N Network GC system/5975 Inert × L
Mass selective Detector at 70 eV and 20°C. The GC col-
umn was a CP-S-il 8 CB LB, fused silica capillary col-
umn (0.25 mm × 30 m, film thickness 0.25 μm). Helium
was used as carrier gas at a flow rate of 1.2 ml/min. The
injector port was maintained at 250°C; the oven tem-
perature was programmed at 5°C/min from 70°C to 300°
C. A solution of each fraction was prepared in chloro-
form at a concentration of 10% (wt/v). To 90 μlo ft h i s
solution, 10 μl of trimethyl sulfonium hydroxide
(TMSH) was added and 1 μl of the resulting mixture
was injected into the GC -MS apparatus. The constitu-
ents were identified by comparing their mass spectra
data with those stored in NIST05 and Wiley237 data-
base libraries.
Aluminium sheet pre-coated with silica gel 60 GF254
(Merck) was used for thin layer chromatography (TLC).
The spots were visualized under UV light (254 and 366
nm) with a UV lamp model 52-58 mineralight, and
sprayed with 50% aqueous solution of H2SO4 followed
by heating at 100°C.
IR spectra were measured with KBr disks using FT-IR-
8400 S Shimadzu spectrophotometer. EI-MS were car-
ried out on a GCT Premier CAB109 TOF mass spectro-
meter.
1H-,
13C-NMR and 2D-NMR (COSY
1H-
1H,
HMBC and HSQC) spectra were recorded in acetone-d6
(500 MHz for
1H and 125 MHz for
13C) on a Brücker-
Avance-500 MHz NMR spectrometer.
(5S,6R,8aR)-5-(carboxymethyl)-3,4,4a,5,6,7,8,8a-octahy-
dro-5,6,8a-trimethylnaphthalenecarboxylic acid (1):
White powder;
13C NMR (100 MHz, CDCl3 +C D 3OD):
δ 14.9 (5-Me), 17.8 (C-4), 20.7 (6-Me), 21.0 (8a-Me),
25.3 (C-7), 27.0 (C-3), 29.4 (C-8), 35.2 (C-6), 37.5 (C-
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Page 2 of 88a), 38.5 (C-5), 43.6 (C-1’), 44.6 (C-4a), 136.9 (C-2),
142.6 (C-1), 169.3 (1-COOH), 175.4 (C-2’); FABMS: m/z
279 ([M - H]
+, 98), 153 (100), 151 (44), 46 (13);
HRFABMS: m/z 279.1592 (calcd. for C16H23O4:
279.1596).
Methyl 3,4,5-trihydroxybenzoate (2): Colorless needles;
13C NMR (100 MHz, CDCl3): δ 51.7 (OCH3), 109,8 (C-
2/C-6), 125.2 (C-1), 148.4 (C-3/C-5), 138.9 (C-4), EIMS:
m/z 184 ([M]
+, 99), 153 (100), 125 (14), 107 (2), 79 (3);
HREIMS: m/z 184.0370 (calcd. for C8H8O5: 184.0372).
Benzene-1,2,3-triol (3): White powder;
13CN M R( 1 0 0
MHz, CDCl3): δ 110.2 (C-4/C-6), 124.6 (C-5), 138.5 (C-
2), 148.8 (C-1/C-3); EIMS: m/z 126 ([M]
+, 100), 108
(21), 80 (24), 52 (27); HREIMS: m/z 126.0312 (calcd. for
C6H6O3: 126.0317).
2,3-dihydroxypropyltriacontanoate (4): Whitish gum;
13C NMR (125 MHz, CDCl3): δ 14.2 (CH3), 22.7-34.2
(28 CH2), 63.4 (C-3), 65.2 (C-1), 70.3 (C-2), 172.3
(COO); EIMS: m/z 43 (100), 57 (80), 71 (44), 83 (64), 85
(28), 97 (69), 99 (7), 111 (37), 125 (19), 127 (3), 139 (8),
141 (3), 153 (5).
Microorganisms and growth conditions
The microorganisms used in this study consisted of two
Gram (+) bacteria (Enterococcus faecalis ATCC 10541
and Staphylococcus aureus ATCC 25922); six Gram (-)
bacteria (Pseudomonas aeruginosa ATCC 27853, Escher-
ichia coli ATCC 11775, Klebsiella pneumoniae
ATCC13883, Salmonella typhi ATCC 6539, Proteus mir-
abilis and Shigella flexneri); and 10 yeasts (Candida
albicans ATCC 9002, C. albicans ATCC 2091, C. albi-
cans ATCC 24433, C. parapsilosis ATCC 22019, C. lusi-
taniae ATCC 200950, C. tropicalis ATCC 750, C. krusei
ATCC 6258, C. guillermondi, C. glabbrata IP 35 and
Cryptococcus neoformans IP 95026). The reference
strains (ATCC) were obtained from American Type
Culture Collection (Rockville, USA). The two clinical
bacterial isolates were collected from “Centre Pasteur”
(Yaoundé, Cameroon) and the two IP fungal strains
were obtained from “Institute Pasteur” (Paris, France).
The bacterial and fungal strains were grown at 35°C and
maintained on nutrient agar (NA, Conda, Madrid,
Spain) and Sabouraud Dextrose Agar (SDA, Conda)
respectively.
Antimicrobial assays
The minimum inhibitory concentration (MIC) of the
crude methanol extract, fractions and isolated com-
pounds were determined through broth microdilution
method in 96-well micro-titre plates as described by
Zgoda and Porter [13]. The 96-well plates were prepared
by dispensing into each well 100 μl of Mueller Hinton
broth for bacteria and Sabouraud Dextrose broth for
yeasts. The test substances were initially prepared in
10% ethanol/tween 80 in broth medium at 3124.8 μg/ml
(methanol extract and fractions), 1250 μg/ml (isolated
compounds) and 50 μg/ml (reference antibiotics). A
volume of 100 μl of each test sample was added into the
first wells of the micro-titre plate. Serial two-fold dilu-
tions of these test samples were made and 100 μlo f
inoculum standardized at 10
6 CFU/ml for bacteria or
2.5 × 10
5 CFU/ml for yeasts (at 600 nm, Jenway 6105
UV/Vis spectrophotometer- 50 Hz/60 Hz) [14] was then
added into each well. The last wells (N°12) served as
sterility controls (contained broth only) or negative con-
trol (broth plus inoculum). This gave final concentration
ranges of 781.25-0.76 μg/ml, 312.50-0.30 μg/ml and
12.50-0.01 μg/ml for the methanol extract or fractions,
isolated compounds and reference substances respec-
tively. The plates were sealed with parafilm, then agi-
tated with a plate shaker to mix their contents and
incubated at 35°C for 24 h for bacteria and 48 h for
yeast.
The MICs of each test sample was detected following
addition of 50 μl( 0 . 2m g / m l )p-iodonitrotetrazolium
chloride (INT, Sigma-Aldrich, South Africa) solution for
bacteria. Viable bacteria reduced the yellow dye to a
pink colour. For yeast, MICs were determined by visua-
lising the turbidity of the wells. The MIC corresponded
to the lowest well concentration where no colour or tur-
bidity change was observed, indicating no growth of
microorganism. The MBC or MFC was determined by
adding 50 μl aliquots of the clear wells to 150 μlo f
freshly prepared broth medium and incubating at 35
°C
f o r4 8h .T h eM B Co rM F Cw a sr e g a r d e da st h el o w e s t
concentration of test sample which did not produce a
c o l o u ro rt u r b i d i t yc h a n g ea sa b o v e .A l lt e s t sw e r ep e r -
formed in triplicates.
DPPH radical scavenging activity
Radical scavenging activity of test samples (methanol
extract, fractions and isolated compounds) was deter-
mined spectrophotometrically (Jenway, spectrophot-
ometer model 1605) at 517 nm under UV/Visible light
using DPPH radical [15]. The methanol extract and
fractions, isolated compounds, and L-ascorbic acid were
prepared in methanol and tested at concentration ranges
of 200 to 6.25 μg/ml, 64 to 0.25 μg/ml and 8 to 0.25 μg/
ml respectively. A volume of 900 μl of DPPH
· solution
(20 mg/l) was mixed with 100 μl of test sample in a
curve and the absorbance (Ab) was read immediately
and after 30 min incubation at room temperature (As).
The experiments were carried out in triplicate. The per-
centages of DPPH
· scavenged (RSa %) by test samples
were calculated as:
Rsa(%)=
[Ab − As]
Ab
× 100
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sponding to the amount of sample necessary to decrease
by 50% the amount of free radical DPPH was deter-
mined by plotting the scavenging activity against the
logarithm of sample concentration [16].
Statistical analysis
The data on antioxidant activity were subjected to the
one-way analysis of variance (ANOVA) and results were
expressed (where appropriate) as mean ± standard
deviation. Differences between means of samples were
compared using Duncan’s multiple range tests at P
<0.05.
Results and discussion
Chemical composition and antimicrobial activity
The qualitative analysis of the methanol extract and
fractions of E. abyssinica revealed the presence of alka-
loids, flavonoids, tannins, saponins and cardiac glyco-
s i d e s( T a b l e1 ) .T h e s er e s u l t ss h o was i m i l a r i t yi n
chemical composition between Entada abyssinica and
Entada africana as well as Entada phaseoloides [17].
Lipid components identified in n-hexane fraction were
mainly saturated and unsaturated fatty acids (Table 2).
The structures of the isolated compounds from E. abys-
sinica were established by spectroscopic analysis [IR, EI-
MS, H
1 and C
13 NMR spectra in conjunction with 2D
experiments (COSY
1H-
1H, HMBC and HSQC)] and
direct comparison with published data. The compounds
were identified as: (5S,6R,8aR)-5-(carboxymethyl)-
3,4,4a,5,6,7,8,8a-octahydro-5,6,8a-trimethylnaphthalene-
carboxylic acid (1) [18]; methyl 3,4,5-trihydroxybenzoate
(methyl gallate) (2) [19]; benzene-1,2,3-triol (pyrogallol)
(3) [20] and 2,3-dihydroxypropyltriacontanoate (4)
(Figure 1).
The results of the antibacterial and antifungal activ-
ities of the methanol extract, fractions and isolated
compounds are reported in Table 3. These substances
displayed varied antibacterial and antifungal activities
across the studied pathogens. The observed wide range
of antimicrobial properties for the methanol extract and
fractions can be explained by the presence of various
groups of potentially active classes of secondary meta-
bolites (Table 1). Indeed flavonoids [21], saponins [22],
polyphenols [23], cardiac glycosides [24], coumarines
[25], tannins [26], triterpenes and alkaloids [27,28] have
been reported to possess antimicrobial activities. It was
noted that the bacterial agents were more susceptible to
the tested samples than yeasts. Yeasts like other fungi
are eukaryotic organism with more complex structural
organisation compared to the simple prokaryotic bacter-
ial cells. This probably explains the difference in sensi-
tivity of these two groups of microorganisms. According
to the classification of Rios and Rico [29], the methanol
extract and fractions (MIC range of 24.4 to 781.2 μg/
ml) could be considered to possess significant (MIC <
100 μg/ml), moderate (100 < MIC = 625 μg/ml) or
weak (MIC > 625 μg/ml) activity against the corre-
sponding pathogens. The antibacterial activity of the
methanol extract of E. abyssinica stem bark reported in
this study are generally high compared to that of Fabry
et al. [30]. The n-hexane fraction acted most on bac-
teria. Its major component, octadecenoic acid, has been
reported to possess antibacterial and antifungal activities
[31]. Moreover, this does not exclude the fact that the
observed antibacterial activity could be a result of the
combined effect of all the detected lipid components in
the n-hexane fraction [32]. The antibacterial mechanism
of action of fatty acids is still poorly understood,
however, the prime target of these compounds is the
cell membrane, where they interfere with the electron
transport chain and oxidative phosphorylation [33]. The
ethyl acetate and n-butanol fractions were generally
more effective on both bacteria and yeasts, while the
aqueous residue fraction displayed greater activity on
yeasts.
Table 1 Phytochemical screening of E. abyssinica methanol extract and fractions
Groups of chemical
constituents
Methanol
extract
n-hexane
fraction
Ethyl acetate
fraction
n-butanol
fraction
Aqueous residue
fraction
Alkaloids ++ + + +
Flavonoids ++ + + +
Coumarins +- + + +
Phenols +- + + +
Tannins +- + + +
Saponins +- + + +
Steroids -- - - -
Chalcones +- + + +
Terpernoids +- + - -
Cardiac glycosides +- - + +
+: presence; -: absence.
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bacteria than yeasts. Compounds 2 and 3 showed greater
activity (MIC = 9.7-312.5 μg/ml) than compounds 1
(MIC = 39.0-312.5 μg/ml) and 4 (78.12-312.5 μg/ml). To
the best of our knowledge, the antimicrobial and antioxi-
dant activities of compound 1 are reported herein for the
first time. The presence of methyl groups on the carbon
r i n g so ft h i sc o m p o u n dc o u l dbe critical for its activity
[34]. Compound 2 is a known medicinally important sub-
stance that was previously isolated from Entada africana
[35], Acer ginnala [36] and Galla rhois,a n dh a sb e e n
reported to possess antimicrobial activities [37] and anti-
asthmatic effects [38]. The activities of this compound
herein reported corroborates those of Jang-Gi et al. [37]
with MICs of 250 and 500 μg/ml on resistant bacterial
strains. Compound 3 (pyrogallol) was as well active on
both bacteria (MIC of 9.7 to 78.1 μg/ml) and yeasts (MIC
of 78.1 to 156.2 μg/ml), this antimicrobial activity was
found to be greater in comparison to that reported by Jin
et al. [20]. Pyrogallol contains both phenolic hydroxyl
groups and a system of delocalized electrons, conditions
critical for its antimicrobial activity [20]. The presence of
hydroxyl groups on compounds 2 and 3 could be respon-
sible for the observed antimicrobial activity. Compound 4
recorded weak and selective antimicrobial activities
against the tested microorganisms and these activities
could be due to the 2,3-dihydroxypropyl moiety [39].
Antioxidant activity
The free radical scavenging activities of samples (RSa50)
are reported in Table 4. The ethyl acetate fraction
(RSa50 of 3.07 μg/ml) showed the greatest activity
while the n-hexane fraction had the least (RSa50 of
35.87 μg/ml). Phenols, flavonoids, saponins and tannins
identified in the extract and fractions may be res-
ponsible for the observed antioxidant activities [40].
Compounds 2, 3 (phenolic compounds) and 4 (fatty
ester) demonstrated interesting radical scavenging
activities (RSa50 of 1.45, 1.45 and 1.60 μg/ml respec-
tively. The antioxidative effects of phenolic compounds
(2 and 3) are mainly due to their redox properties,
which can play an important role in absorbing and
neutralizing free radicals, quenching singlet and triplet
oxygen, or decomposing peroxides [40]. It is known
that the antioxidant activity of an aromatic compound
is proportional to the number of hydroxyl groups it
contains [41]. This probably explains the high radical
scavenging activities of compounds 2 and 3.T h ea c t i v -
ity of 2 in this assay was higher than that (RSa50 =2 . 8
μg/ml) reported by Seong et al. [37] against DPPH free
radical.
Figure 1 Chemical structures of compounds isolated from
Entada abyssinica ethyl acetate fraction. 1:(5S,6R,8aR)-5-
(carboxymethyl)-3,4,4a,5,6,7,8,8a-octahydro-5,6,8a-
Trimethylnaphthalenecarboxylic acid; 2: methyl 3,4,5-
trihydroxybenzoate; 3: benzene-1,2,3-triol; 4: 2,3-
dihydroxypropyltriacontanoate.
Table 2 Percentage composition of chemical constituents in n-hexane fraction of E.abyssinica stem bark
Chemical constituents/Molecular ion (m/z) Chemical structure %
Hexadecanoic acid
(C16 H32 O2)
CH3-CH2-[CH2]12-CH2-COOH 17.86
9,12-Octadecadienoic acid (Z,Z)
(C18 H32 O2)
CH3-[CH2]4-CH = CH-CH2-CH = CH-[CH2]7-
COOH
21.14
9-Octadecenoic acid (Z)
(C18 H34 O2)
CH3-[CH2]6-CH2-CH = CH-[CH2]7-COOH 27.78
Octadecanoic acid
(C18 H36 O2)
CH3-CH2-[CH2]14-CH2-COOH 2.92
298(M+ 1), 257(5), 189(26), 121(30), 107(60), 95(100), 81(54), 55(71), 41(46), 29(10) nd 4.27
327(M+ 1), 290(2), 274(7), 189(31), 175(16), 120(63), 107(74), 95(100), 55(48), 41(46) nd 8.50
347(M+ 1), 330(77), 315(30), 256(15), 203(36), 175(49), 139(100), 119(57), 107(75), 95(82), 79(64), 55
(68), 41(55)
nd 17.50
Total 99.97
nd: not determined.
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substances (μg/ml)
Microorganisms Parameters Test samples
a
ME HF EF nB A R 1234 R e f
Gram (-) bacteria
Pseudomonas MIC 195.3 24.4 781.2 390.6 781.2 39.0 9.7 9.7 312.5 1.5
aeruginosa MBC 781.2 390.6 na
b na na 156.2 19.5 9.7 > 312.5 12.5
Proteus MIC 195.3 390.6 390.6 781.2 na 156.2 19.5 39.0 na 0.3
mirabilis MBC 781.2 na 390.6 na na 156.2 39.0 156.2 na 1.5
Shigella flexneri MIC 781.2 48.8 390.6 24.4 390.6 78.1 39.0 39.0 na 0.2
MBC na 390.6 390.6 195.3 na 156.2 156.2 78.1 na 6.2
Klebsiella MIC 781.2 24.4 97.6 781.2 na 78.1 19.5 78.1 na 0.2
pneumoniae MBC na 195.3 390.6 na na 156.2 39.0 156.2 na 3.1
Salmonella typhi MIC 781.2 390.6 97.6 781.2 na 156.2 39.0 78.1 na 0.3
MBC na na 390.6 na na 312.5 156.2 156.2 na 1.5
Escherichia coli MIC 781.2 24.4 97.6 24.4 na 78.1 39.0 156.2 312.5 0.2
MBC na 390.6 390.6 390.6 na 312.5 312.5 156.2 > 312.5 1.5
Gram (+) bacteria
Enterococcus MIC 195.3 390.6 390.6 781.2 na 78.1 39.0 78.1 na 0.2
faecalis MBC na 781.2 781.2 na na 312.5 312.5 156.2 na 1.5
Staphylococcus MIC 390.6 195.3 97.6 781.2 390.6 78.1 39.0 78.1 na 1.5
aureus MBC na na 390.6 na na 39.0 156.2 156.2 na 12.0
Yeast
C. albicans MIC na na 195.2 390.6 195.3 312.5 312.5 78.1 na 0.01
ATCC 2091 MFC na na 195.3 390.6 1953 312.5 312.5 156.2 na 0.08
C. albicans MIC 781.2 781.2 195.3 195.3 195.3 312.5 156.2 156.2 312.2 0.01
ATCC9002 MFC na na 781.2 195.3 390.6 312.5 156.2 156.2 > 312.5 0.08
C. albicans MIC 195.3 390.6 195.3 390.6 195.3 156.2 312.5 78.1 na 0.02
ATCC 24433 MFC 781.2 na 195.3 na 195.3 312.5 312.5 156.2 na 0.02
Candida MIC 781.2 781.2 195.3 390.6 390.6 312.5 156.2 78.1 na 0.01
parapsilosis MFC na 390.6 781.2 390.6 781.2 312.5 156.2 156.2 na 0.08
Candida MIC 195.3 na 48.8 390.6 195.3 312.5 312.5 78.1 na 0.04
tropicalis MFC 781.2 na 390.6 781.2 195.3 312.5 312.5 156.2 na 0.08
Candida krusei MIC na 781.2 781.2 390.6 195.3 312.5 312.5 78.1 na 0.04
MFC na na na 390.6 195.3 312.5 312.5 156.2 na 0.04
Candida glabrata MIC na 781.2 195.3 390.6 390.6 78.1 312.5 78.1 na 0.02
MFC na na 195.3 na 781.2 78.1 312.5 156.2 na 0.02
Candida MIC 781.2 390.6 195.3 195.3 195.3 156.2 312.5 78.1 na 0.01
lusitaniae MFC na 781.2 390.6 195.3 195.3 156.2 312.5 78.1 na 0.08
Cryptococcus MIC 390.6 781.2 97.6 390.6 195.3 195.3 78.1 78.1 na 1.00
neoformans MFC na na 781.2 390.6 195.3 312.5 156.2 78.1 na 1.00
Candida MIC 781.2 781.2 195.3 390.6 390.6 312.5 156.2 78.1 na 0.01
guillermondi MFC na na na na 781.2 312.5 156.2 156.2 na 0.08
aME: methanol extract; HF: n-hexane fraction; EF: Ethyl acetate fraction; nB: n-butanol fraction; AR: Aqueous residue; 1: (5S,6R,8aR)-5-(carboxymethyl)-
3,4,4a,5,6,7,8,8a-octahydro-5,6,8a-Trimethylnaphthalenecarboxylic acid; 2: methyl 3,4,5-trihydroxybenzoate; 3: benzene-1,2,3-triol; 4: 2,3-
dihydroxypropyltriacontanoate and Ref (reference drugs): ciprofloxacin for bacteria and nystatin for yeasts.
bna: not active at concentrations upto 781.2 μg/ml.
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The results obtained from this study reveal that the
stem bark of E. abyssinica may be useful in the develop-
ment of an antimicrobial phytomedicine which can be
standardised using the isolated compounds.
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